Mass Drug Administration and beyond: How can we strengthen health systems to deliver complex interventions to eliminate neglected tropical diseases?

BMC Proceedings

Volumn 9, Issue , 2015, Pages

  Macpherson, Eleanor E ^a   Adams, Emily R ^a   Bockarie, Moses J ^a   Hollingsworth, T Deirdre ^b   Kelly Hope, Louise A ^a   Lehane, Mike ^a   Kovacic, Vanja ^a   Harrison, Robert A ^a   Paine, Mark J I ^a   Reimer, Lisa J ^a   Torr, Stephen J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; IVERMECTIN; VENOM;

AFRICAN TRYPANOSOMIASIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DENGUE; DIAGNOSTIC TEST; DISABILITY; DISEASE CONTROL; DISEASE ELIMINATION; DISEASE TRANSMISSION; ENVIRONMENTAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; LOIASIS; LYMPHATIC FILARIASIS; MASS DRUG ADMINISTRATION; MORBIDITY; NEGLECTED TROPICAL DISEASE; ONCHOCERCIASIS; PROGRAM SUSTAINABILITY; RAPID TEST; SCHISTOSOMIASIS; SNAKEBITE; SOCIAL DETERMINANTS OF HEALTH; TROPICAL DISEASE; VECTOR CONTROL; VISCERAL LEISHMANIASIS;

EID: 85018499065     PISSN: None     EISSN: 17536561     Source Type: Journal    
DOI: 10.1186/1753-6561-9-S10-S7     Document Type: Conference Paper

References (27)

1. WHO: Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. 2010, WHO: Geneva
2. WHO: Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. 2012, WHO: Geneva
3. WHO: Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases: summary. 2013, World Health Organization,: Geneva
4. Rebollo M P, Bockarie M J: Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. Expert Rev Anti Infect Ther. 2013, 11 (7): 723-31.
5. Rollinson D, et al: Time to set the agenda for schistosomiasis elimination. Acta tropica. 2013, 128 (2): 423-440.
6. Taylor M J, Hoerauf A, Bockarie M: Lymphatic filariasis and onchocerciasis. Lancet. 2010, 376 (9747): 1175-85.
7. Wanji S, et al: Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors. 2009, 2 (1): 39-
8. Williams D, et al: The Global Snake Bite Initiative: an antidote for snake bite. The lancet. 2010, 375 (9708): 89-91.
9. Reimer L J, et al: Fit for purpose: do we have the right tools to sustain NTD elimination?. 2014
10. Njelesani J, et al: A Systematic Approach to Capacity Strengthening of Laboratory Systems for Control of Neglected Tropical Diseases in Ghana, Kenya, Malawi and Sri Lanka. PLoS Negl Trop Dis. 2014, 8 (3): e2736-
11. van den Berg H, Kelly-Hope L A, Lindsay S W: Malaria and lymphatic filariasis: the case for integrated vector management. The Lancet infectious diseases. 2013, 13 (1): 89-94.
12. Kelly-Hope L A, Molyneux D H, Bockarie M J: Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity. Parasit Vectors. 2013, 6: 39-
13. Reimer L J, et al: Insecticidal bed nets and filariasis transmission in Papua New Guinea. New England Journal of Medicine. 2013, 369 (8): 745-753.
14. Gutiérrez J M, et al: The Need for Full Integration of Snakebite Envenoming within a Global Strategy to Combat the Neglected Tropical Diseases: The Way Forward. PLoS Negl Trop Dis. 2013, 7 (6): e2162-
15. Gyapong J O, et al: Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. The Lancet. 2010, 375 (9709): 160-165.
16. Brantus P: Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis. Ann Trop Med Parasitol. 2009, 103 (Suppl 1): S5-10.
17. Stanton M C, Bockarie M J, Kelly-Hope L A: Geographical Factors Affecting Bed Net Ownership, a Tool for the Elimination of Anopheles-Transmitted Lymphatic Filariasis in Hard-to-Reach Communities. PloS one. 2013, 8 (1): e53755-
18. Stanton M C, et al: Baseline drivers of lymphatic filariasis in Burkina Faso. Geospatial health. 2013, 8 (1): 159-173.
19. Harrison R A, et al: Research strategies to improve snakebite treatment: Challenges and progress. Journal of Proteomics. 2011, 74 (9): 1768-1780.
20. Molesworth A M, et al: Geographic information system mapping of snakebite incidence in northern Ghana and Nigeria using environmental indicators: a preliminary study. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2003, 97 (2): 188-192.
21. Smith D L, et al: A sticky situation: the unexpected stability of malaria elimination. Philosophical Transactions of the Royal Society B: Biological Sciences. 2013, 368 (1623): 20120145-
22. Killeen G F, et al: Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa?. Lancet Infect Dis. 2002, 2 (10): 618-27.
23. Manderson L, et al: Social research on neglected diseases of poverty: continuing and emerging themes. PLoS Negl Trop Dis. 2009, 3 (2): e332-
24. Kagbadouno M S, et al: Epidemiology of Sleeping Sickness in Boffa (Guinea): Where Are the Trypanosomes?. PLoS Negl Trop Dis. 2012, 6 (12): e1949-
25. Meredith S E, Cross C, Amazigo U V: Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda. Health Res Policy Syst. 2012, 10: 16-
26. Amazigo U, et al: Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med. 2007, 64 (10): 2070-82.
27. Amazigo U V, et al: Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002, 96 (Suppl 1): S75-92.